DZ Bank’s Ascendis Pharma A/S ASND Stock Holding History

DZ Bank’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.49M	Sell	23,997 -24,100	-50%	-$5.4M	﹤0.01%	487
2025 Q4	$10.3M	Sell	48,097 -5,633	-10%	-$1.16M	0.01%	372
2025 Q3	$10.7M	Buy	+53,730	New	+$10M	0.01%	373
2025 Q2	–	Sell	-2,524	Closed	-$393K	–	953
2025 Q1	$393K	Sell	2,524 -2,111	-46%	-$302K	﹤0.01%	790
2024 Q4	$638K	Hold	4,635	–	–	﹤0.01%	711
2024 Q3	$692K	Hold	4,635	–	–	﹤0.01%	714
2024 Q2	$632K	Buy	+4,635	New	+$631K	﹤0.01%	732
2018 Q2	–	Sell	-19,000	Closed	-$1.24M	–	865
2018 Q1	$1.24M	Buy	+19,000	New	+$1.07M	﹤0.01%	614

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DZ Bank's ASND Position: Q1 2026 in Review

DZ Bank reduced its Ascendis Pharma A/S (ASND) stake by 50% in Q1 2026, selling an estimated $5.4M and leaving 23,997 shares worth $5.49M. The position accounts for ﹤0.01% of the portfolio, ranked #487.

DZ Bank first reported a position in ASND in Q1 2018 and has held it in 8 quarters since. The position peaked at $10.7M in Q3 2025. 273 funds tracked by Wall St. Rank hold ASND as of Q1 2026.

DZ Bank held 23,997 shares of Ascendis Pharma A/S worth $5.49M as of Q1 2026.
DZ Bank sold 24,100 Ascendis Pharma A/S shares in Q1 2026, an estimated $5.4M.
Ascendis Pharma A/S made up ﹤0.01% of DZ Bank's portfolio in Q1 2026, its #487 holding.
DZ Bank first reported a position in Ascendis Pharma A/S in Q1 2018 and has held it in 8 quarters since.
DZ Bank's Ascendis Pharma A/S position peaked at $10.7M in Q3 2025.
273 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.

Based on DZ Bank's 13F filing for Q1 2026, filed 15 May 2026.